Does SELUMETINIB Cause Disease progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Disease progression have been filed in association with SELUMETINIB (KOSELUGO). This represents 1.7% of all adverse event reports for SELUMETINIB.
20
Reports of Disease progression with SELUMETINIB
1.7%
of all SELUMETINIB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From SELUMETINIB?
Of the 20 reports, 2 (10.0%) resulted in death, 6 (30.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for SELUMETINIB.
What Other Side Effects Does SELUMETINIB Cause?
Blood creatine phosphokinase increased (105)
Rash (89)
Off label use (78)
Paronychia (73)
Dermatitis acneiform (61)
Diarrhoea (59)
Fatigue (54)
Acne (52)
Nausea (49)
Death (47)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which SELUMETINIB Alternatives Have Lower Disease progression Risk?
SELUMETINIB vs SEMAGLUTIDE
SELUMETINIB vs SEMUSTINE
SELUMETINIB vs SENNA LEAF
SELUMETINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SELUMETINIB vs SENNOSIDES